Binding of the [I-125]3 beta(iodophenyl)tropan-2 beta-carboxylic acid isopropyl ester to the dopamine transporter at a physiologically relevant temperature: Mutually exclusive binding and different ionic requirements for various uptake blockers and substrates

被引:0
|
作者
Chen, NH [1 ]
Wang, YL [1 ]
Reith, MEA [1 ]
机构
[1] UNIV ILLINOIS, COLL MED, DEPT BIOMED & THERAPEUT SCI, PEORIA, IL 61656 USA
关键词
dopamine transporter; RTI-121; binding; cocaine; ion-dependence; rat striatum;
D O I
10.1002/(SICI)1098-2396(199702)25:2<155::AID-SYN6>3.0.CO;2-B
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study describes the binding of cocaine analog [I-125]3 beta-(iodophenyl)tropan-2 beta-carboxylic acid isopropyl ester ([I-125]RTI-121), a highly selective ligand for the dopamine transporter (DAT), to rat striatal synaptosomal membranes at 37 degrees C. Saturation analysis of [I-125]RTI-121 binding revealed a single binding site with similar affinity for RTI-121 at both 50 and 134 mM NaCl. However, the density of binding sites was reduced at 134 mM NaCl. Various uptake blockers and substrates of the DAT monophasically inhibited the specific binding of [I-125]RTI-121. Increasing the NaCl concentration from 50 mM to 134 mM enhanced the affinity of the substrate dopamine and amphetamine for the DAT, without affecting that of the uptake blockers. At 134 mM NaCl, the copresence of GBR12935, BTCP, cocaine, amphetamine, or dopamine decreased the affinity of RTI-121 to the extent predicted by a model in which the binding of all compounds is mutually exclusive. This, along with a different NaCl sensitivity for blockers and substrates, suggests that the two categories of compounds recognize nonidentical but overlapping binding domains on the DAT. In contrast, the mutually exclusive binding with similar NaCl sensitivity for RTI-181 and the other uptake blockers tested here suggests the involvement of common binding domains in the recognition of these blockers. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 6 条
  • [1] Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 beta-(4-[I-125]iodophenyl)tropan-2 beta-carboxylic acid isopropyl ester ([I-125]RTI-121)
    Lever, JR
    Scheffel, U
    Stathis, M
    Seltzman, HH
    Wyrick, CD
    Abraham, P
    Parham, K
    Thomas, BF
    Boja, JW
    Kuhar, MJ
    Carroll, FI
    NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (03): : 277 - 284
  • [2] Modeling of the interaction of Na+ and K+ with the binding of the cocaine analogue 3 beta-(4-[I-125]iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester to the dopamine transporter
    Chen, NH
    Ding, JH
    Wang, YL
    Reith, MEA
    JOURNAL OF NEUROCHEMISTRY, 1997, 68 (05) : 1968 - 1981
  • [3] BINDING OF THE COCAINE ANALOG 2-BETA-CARBOMETHOXY-3-BETA-(4-[I-125]IODOPHENYL)TROPANE TO SEROTONIN AND DOPAMINE TRANSPORTERS - DIFFERENT IONIC REQUIREMENTS FOR SUBSTRATE AND 2-BETA-CARBOMETHOXY-3-BETA-(4-[I-125]IODOPHENYL)TROPANE BINDING
    WALL, SC
    INNIS, RB
    RUDNICK, G
    MOLECULAR PHARMACOLOGY, 1993, 43 (02) : 264 - 270
  • [4] SELECTIVE LABELING OF THE DOPAMINE TRANSPORTER BY THE HIGH-AFFINITY LIGAND 3-BETA-(4-[I-125]IODOPHENYL)TROPANE-2-BETA-CARBOXYLIC ACID ISOPROPYL ESTER
    BOJA, JW
    CADET, JL
    KOPAJTIC, TA
    LEVER, J
    SELTZMAN, HH
    WYRICK, CD
    LEWIN, AH
    ABRAHAM, P
    CARROLL, FI
    MOLECULAR PHARMACOLOGY, 1995, 47 (04) : 779 - 786
  • [5] Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 {3 beta-(3p-chlorophenyl)tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride}
    Fleckenstein, AE
    Pogun, S
    Carroll, FI
    Kuhar, MJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 279 (01): : 200 - 206
  • [6] RADIOSYNTHESIS OF A PHOTOAFFINITY PROBE FOR THE COCAINE RECEPTOR OF THE DOPAMINE TRANSPORTER - 3-BETA-(P-CHLOROPHENYL)TROPAN-2-BETA-CARBOXYLIC ACID M-([I-125]-IODO)-P-AZIDOPHENETHYL ESTER ([I-125]-RTI-82)
    LEVER, JR
    CARROLL, FI
    PATEL, A
    ABRAHAM, P
    BOJA, J
    LEWIN, A
    LEW, R
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1993, 33 (12): : 1131 - 1137